Article
Co-expression of NRP1 and p-EGFR in the prognosis of patients with head and neck squamous cell carcinoma
2025-09-08
Abstract excerpt
<title>Abstract</title> <p>Background Aberrant activation of the epidermal growth factor receptor (EGFR) signaling pathway is critically involved in the pathogenesis of head and neck squamous cell carcinoma (HNSCC). While the monoclonal antibody cetuximab has demonstrated significant efficacy in the initial treatment of HNSCC, the development of drug resistance has limited its therapeutic success. Consequently, i...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5ffad4be-1da1-5821-a738-ec9b58c339bb
- DOI
- 10.21203/rs.3.rs-6354735/v1
